Maritess Esguerra is a seasoned professional in the field of pharmacovigilance, currently serving as the Senior PV Director at Genentech/Roche. With over 25 years of experience in drug safety and risk management, Maritess has a proven track record of ensuring the safety and well-being of patients through effective pharmacovigilance and vigilance strategies.
Throughout her career, Maritess has demonstrated a deep understanding of global regulatory requirements and industry best practices, allowing her to navigate complex safety challenges with ease across a variety of product types and spanning across their development cycles. She is known for her strategic approach to pharmacovigilance, leading teams and projects to successful achievements, always staying ahead of emerging trends and proactively addressing potential safety issues while bridging the gap between global and local functions around the world.
Maritess is a strong advocate for patient safety and is dedicated to fostering inclusion and a culture of continuous improvement while exploring automation and innovation to create efficiencies. As a speaker at the World Patient Safety Congress Europe 2026, Maritess will share her insights on addressing key challenges for safety professionals in today's rapidly evolving healthcare landscape. Attendees can expect to gain valuable knowledge and practical strategies for enhancing patient safety and driving excellence in pharmacovigilance and vigilance.